Connect Biopharma Holdings CNTB
NASDAQ CNTB
$0.83 -0.05 (-5.70%)
As of: Oct 21, 2026 · 2:02 PM EDT

Connect Biopharma Holdings (CNTB) EBIT Margin (2024 - 2026)

Updated

Connect Biopharma Holdings (CNTB) recorded EBIT Margin of -635.98% in Q2 2026, up 27330.68 percentage points from -27966.67% a year earlier and up 10965.79 percentage points from the prior quarter.

Analysis

Connect Biopharma Holdings (CNTB) EBIT Margin (2024 - 2026) Analysis & Trends

On a TTM basis, Connect Biopharma Holdings' EBIT Margin came in at -2384.49% as of Jun 30, 2026, up 75.36 percentage points year-over-year; for FY2025, it was -90740.63%, down 90654.38 percentage points from FY2024.

  • Across earlier years, EBIT Margin came in at -86.24% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,134.61 Bn 1,103.20 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 616.25 Bn 534.77 Bn 17.26 Bn 28.21%
3 AbbVie 501.45 Bn 474.56 Bn 12.70 Bn 37.86%
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.44 Bn 235.12 Bn 12.86 Bn 20.57%
7 Amgen 235.87 Bn 191.27 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -133.21%
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn 28.37%
10 Connect Biopharma Holdings 51.90 Mn -124.78 Mn - -635.98%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -635.98%
Mar 31, 2026 -11,601.78%
Sep 30, 2025 -110,481.25%
Jun 30, 2025 -27,966.67%
Dec 31, 2024 -1,378.08%
Sep 30, 2024 -1,135.85%
API Access

Connect Biopharma Holdings EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CNTB&period=max&api_key=YOUR_API_KEY